PLUS1
6,13
0,00 (0,0%)
0,00 (0,0%)
Upgrade auf Real-Time
Vormarkt
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
Best deals to access real time data! |
|
Trade Alert US
Monthly Subscription
for only
|
|
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
|
|
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
|
|
VAT not included
|
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Zymeworks Inc | ZYME | NYSE | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
 |
|
|---|---|---|---|---|
| 0,00 | 0,0% | 6,13 | 10:07:48 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 6,13 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4,56 - 39,41 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 6,13 | USD |
Zeitraum:
Zeichenmodus:
Finanzwerte ZYME
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 354,14M | 57,77M | 57,74M | US$ 26,61M | US$ - | -4,03 | -1,40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | 505,00k | 0,80% |
News Zymeworks
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 23.5.2022 | 12:27 | TipRanks | H.C. Wainwright Sticks to Its Buy Rating for Zymeworks.. |
| 20.5.2022 | 22:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 20.5.2022 | 17:20 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
| 20.5.2022 | 15:15 | Business Wire | Zymeworks’ Board of Directors Unanimously Rejects.. |
| 19.5.2022 | 19:00 | PR Newswire (US) | ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT.. |
| 09.5.2022 | 04:31 | TipRanks | Zymeworks (ZYME) Gets a Buy Rating from Stifel Nicolaus |
| 08.5.2022 | 17:06 | TipRanks | SVB Securities Thinks Zymeworks’ Stock is Going to Recover |
| 06.5.2022 | 03:15 | TipRanks | Analysts Conflicted on These Healthcare Names: Zymeworks.. |
| 05.5.2022 | 11:10 | TipRanks | Wells Fargo Thinks Zymeworks’ Stock is Going to Recover |
| 04.5.2022 | 22:15 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 04.5.2022 | 22:15 | Business Wire | Zymeworks Provides Corporate Update and Reports First.. |
| 04.5.2022 | 06:16 | TipRanks | Wells Fargo Sticks to Its Buy Rating for Zymeworks (ZYME) |
Forum Zymeworks
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ZYME Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 5,44 | 6,23 | 5,10 | 5,82 | 2.081.776 | 0,69 | 12,68% |
| 1 Monat | 5,02 | 7,88 | 4,56 | 6,11 | 3.804.067 | 1,11 | 22,11% |
| 3 Monate | 7,28 | 7,88 | 4,56 | 6,25 | 1.845.236 | -1,15 | -15,8% |
| 6 Monate | 18,39 | 21,44 | 4,56 | 8,74 | 1.433.518 | -12,26 | -66,67% |
| 1 Jahr | 29,07 | 39,41 | 4,56 | 14,30 | 950.239 | -22,94 | -78,91% |
| 3 Jahre | 18,13 | 59,03 | 4,56 | 24,73 | 591.099 | -12,00 | -66,19% |
| 5 Jahre | 13,14 | 59,03 | 4,56 | 23,90 | 390.163 | -7,01 | -53,35% |
